Intranasal fluticasone propionate inhibits allergen induced bone marrow eosinophilia in mice

Pulmonary Pharmacology and Therapeutics

Volumn 15, Issue 2, 2002, Pages 129-134

  Sergejeva, Svetlana ^a   Tomaki, Masafumi ^a   Pullerits, Teet ^a   Zhao, Lin Ling ^a   Johnson, Malcolm ^b   Lötvall, Jan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Bone marrow; Bronchoalveolar lavage fluid; Corticosteroid; Eosinophil

Indexed keywords

ALLERGEN; ALUMINUM; BUFFER; FLUTICASONE PROPIONATE; OVALBUMIN; PHOSPHATE; SODIUM CHLORIDE;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL COUNT; CELL MATURATION; CELL POPULATION; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG SCREENING; EOSINOPHIL; EOSINOPHILIA; EXPOSURE; INHIBITION KINETICS; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT DISEASE; SENSITIZATION; TISSUE;

EID: 0036315426     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.2001.0326     Document Type: Review

References (22)

1. Molecular basis for selective eosinophil trafficking in asthma: A multistep paradigm
2. IL-12 regulates bone marrow eosinophilia and airway eotaxin levels induced by airway allergen exposure
3. Eosinophilopoiesis in a murine model of allergic airway eosinophilia: Involvement of bone marrow IL-5 and IL-5 receptor alpha
4. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation
5. An inhaled corticosteroid, budesonide, reduces baseline but not allergen-induced increases in bone marrow inflammatory cell progenitors in asthmatic subjects
6. Efficacy of inhaled corticosteroids in asthma
7. Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis
8. The effects of glucocorticoids on human eosinophils
9. Delayed eosinophil apoptosis in asthma
10. The nose, the lung and the bone marrow in allergic inflammation
11. Bone marrow in atopy and asthma: Hematopoietic mechanisms in allergic inflammation
12. Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies
13. Rapid increase in bone-marrow eosinophil production and responses to eosinopoietic interleukins triggered by intranasal allergen challenge
14. + cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation
15. Increased mature and immature CCR3 messenger RNA+ eosinophils in bone marrow from patients with atopic asthma compared with atopic and nonatopic control subjects
16. Changes in bone marrow inflammatory cell progenitors after inhaled allergen in asthmatic subjects
17. Intranasal Budesonide inhibits allergen-induced IL-5 production, airways, blood and bone marrow eosinophilia and eosinophilic progenitor expansion in mice
18. Allergen-induced increase in bone marrow progenitors in airway hyperresponsive dogs: Regulation by a serum hemopoietic factor
19. Allergen-induced changes in bone marrow progenitors and airway responsiveness in dogs and the effect of inhaled budesonide on these parameters
20. Mechanisms of allergic pulmonary eosinophilia in the mouse
21. Lung inflammation and epithelial changes in a murine model of atopic asthma
22. Degranulation status of airway tissue eosinophils in mouse models of allergic airway inflammation